Universal DX has initiated a clinical trial for FDA approval of its Signal-C® blood test, designed for early colorectal cancer…
Browsing: Business
The article highlights how consumerization is transforming healthcare, with Exact Sciences’ Cologuard as a key example. Over its 10 years,…
Steward Health Care is selling its physician group to a private equity firm managed by Stewardship, backed by Kinderhook Industries.…
AbbVie is expanding its presence in the gastroenterology market with the FDA approval of Skyrizi for ulcerative colitis. The company…
GI Alliance has announced its partnership with Klara, a healthcare communication platform, to enhance its patient engagement services across the…
Amulet Capital Partners has successfully closed its third niche life sciences fund, raising significant capital to invest in subsectors such…
ZOE, a health tech company specializing in personalized nutrition, has raised $15 million in new funding. The investment will be…
Exact Sciences announced strong financial results for the second quarter of 2024, reporting $699 million in revenue, a 12% increase…
Guardant Health’s newly FDA-approved blood test, Shield, offers a non-invasive screening option for colorectal cancer. This liquid biopsy test detects…
The article on Becker’s ASC Review identifies three major disruptors in the physician acquisition market: Optum, Amazon, and CVS Health.…